Format

Send to

Choose Destination
Tuberculosis (Edinb). 2016 Aug;99 Suppl 1:S16-20. doi: 10.1016/j.tube.2016.05.013. Epub 2016 Jun 16.

TB vaccines in clinical development.

Author information

1
Aeras, Rockville, MD, USA. Electronic address: aginsberg@aeras.org.
2
Statens Serum Institut, Copenhagen, Denmark.
3
South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
4
Jenner Institute, University of Oxford, Oxford, UK.

Abstract

The 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 - 24 April 2015, brought together a wide and diverse community involved in tuberculosis vaccine research and development to discuss the current status of, and future directions for this critical effort. This paper summarizes the sessions on TB Vaccines in Clinical Development, and Clinical Research: Data and Findings. Summaries of all sessions from the 4th Global Forum are compiled in a special supplement of Tuberculosis. [August 2016, Vol 99, Supp S1, S1-S30].

KEYWORDS:

Clinical trial; Immunogenicity; Safety; TB vaccine

PMID:
27470538
DOI:
10.1016/j.tube.2016.05.013
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center